Advanced search×

Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy.

C R Roe, B-Z Yang, H Brunengraber, D S Roe, M Wallace, and B K Garritson

Neurology 71(4):260-4 (2008) PMID 18645163 PMCID PMC2676979

Carnitine palmitoyltransferase II (CPT II) deficiency is an important cause of recurrent rhabdomyolysis in children and adults. Current treatment includes dietary fat restriction, with increased carbohydrate intake and exercise restriction to avoid muscle pain and rhabdomyolysis.

DOI: 10.1212/01.wnl.0000318283.42961.e9
Version: za2963e q8zaa q8zbb q8zc9 q8zdb q8ze2 q8zf5 q8zg1
View PDF

Similar articles you may find interesting…

  1. [Diagnosis and treatment of methylmalonic acidemia in 14 cases].
    Hong H Jin, Li-Ping LP Zou, ... Zhen Z Jin

    Zhonghua Er Ke Za Zhi 42(8):581-4 (2004) PMID 15347443

    The main clinical features of MMA include lethargy, developmental retardation or regradation, convulsion, recurrent vomiting, difficulty with feeding, muscular dystonia, yellowish hair, metabolic acidosis, hyperammonemia and ketonuria, etc. Urine organic acids analysis with GC/MS is critical to the...
  2. Acyl-CoA dehydrogenase deficiency: varieties with neurological involvement.
    Neil N Gordon

    Dev Med Child Neurol 47(3):207-10 (2005) PMID 15739728